Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,540 | 0,560 | 13:03 | |
0,545 | 0,575 | 27.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.06. | FibroBiologics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
16.06. | FibroBiologics, Inc.: FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing | 2 | GlobeNewswire (USA) | ||
16.06. | FibroBiologics, Inc.: FibroBiologics to Present at the BIO International Convention 2025 | 3 | GlobeNewswire (USA) | ||
FIBROBIOLOGICS Aktie jetzt für 0€ handeln | |||||
09.06. | FibroBiologics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
09.06. | FibroBiologics Appoints Jason Davis As CFO | 2 | RTTNews | ||
09.06. | FibroBiologics announces CFO appointment | 1 | Seeking Alpha | ||
09.06. | FibroBiologics appoints new CFO amid clinical trials | 1 | Investing.com | ||
09.06. | Fibrobiologics, Inc.: FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer | 184 | GlobeNewswire (Europe) | HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development... ► Artikel lesen | |
16.05. | Fibrobiologics, Inc.: FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting | 1 | GlobeNewswire (USA) | ||
14.05. | Fibrobiologics, Inc.: FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update | 164 | GlobeNewswire (Europe) | HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of... ► Artikel lesen | |
14.05. | FibroBiologics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
05.05. | FibroBiologics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
29.04. | Fibrobiologics, Inc.: FibroBiologics Presents at the ThymUS 2025 Meeting | 3 | GlobeNewswire (USA) | ||
29.04. | Fibrobiologics, Inc.: FibroBiologics Presenting at the ThymUS 2025 Meeting | 2 | GlobeNewswire (USA) | ||
11.04. | Fibrobiologics, Inc.: FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean | 2 | GlobeNewswire (USA) | ||
08.04. | Fibrobiologics, Inc.: FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics | 1 | GlobeNewswire (USA) | ||
03.04. | Fibrobiologics, Inc.: FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt | 3.606 | GlobeNewswire (Deutschland) | HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (im Folgenden kurz "FibroBiologics"), ein im klinischen Stadium tätiges Biotechnologieunternehmen mit über 240 erteilten... ► Artikel lesen | |
02.04. | Fibrobiologics, Inc.: FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair | 326 | GlobeNewswire (Europe) | HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of... ► Artikel lesen | |
31.03. | Fibrobiologics, Inc.: FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update | 105 | GlobeNewswire (Europe) | Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing... ► Artikel lesen | |
27.03. | Fibrobiologics, Inc.: FibroBiologics Announces 2025 Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 90,70 | -0,60 % | Die nächste Cashcow? Schnelle Prozente mit NetraMark, Moderna, BioNTech | Erinnern Sie sich noch an den Impfstoff-Wettlauf in der Corona-Zeit? Damals bestimmte das Duell zwischen BioNTech und Curevac auch das Geschehen an der Börse. Anleger der ersten Stunde machten schnell... ► Artikel lesen | |
CUREVAC | 4,560 | -0,91 % | EQS-News: CureVac Announces Voting Results of General Meeting | Emittent / Herausgeber: CureVac
/ Schlagwort(e): Hauptversammlung
CureVac Announces Voting Results of General Meeting
24.06.2025 / 22:09 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
MODERNA | 23,305 | +0,17 % | Laboratorios Rovi: FDA approves Moderna vaccine for RSV in adults aged 18 to 59 | ||
PAION | 0,011 | -27,03 % | Paion Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
NOVAVAX | 5,424 | -0,40 % | Novavax Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
4SC | 0,648 | -0,31 % | PTA-News: 4SC AG: Resminostat (Kinselby) negative Empfehlung des CHMP in der EU erhalten | DJ PTA-News: 4SC AG: Resminostat (Kinselby) negative Empfehlung des CHMP in der EU erhalten
Unternehmensmitteilung für den Kapitalmarkt
4SC AG: Resminostat (Kinselby) negative Empfehlung... ► Artikel lesen | |
NANOREPRO | 1,645 | -0,30 % | EQS-DD: NanoRepro AG: Dr. Olaf Stiller, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.05.2025 / 14:00... ► Artikel lesen | |
VIVOSIM LABS | 1,220 | -100,00 % | VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market | SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.... ► Artikel lesen | |
INOVIO PHARMACEUTICALS | 1,840 | +1,10 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)... ► Artikel lesen | |
INFLARX | 0,696 | -0,43 % | InflaRx N.V. - 6-K, Report of foreign issuer | ||
SCORPIUS | 0,072 | 0,00 % | Scorpius Holdings, Inc. - 8-K, Current Report | ||
DEFENCE THERAPEUTICS | 0,470 | +2,17 % | Defence Therapeutics Inc.: Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology | Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
BIOCRYST PHARMACEUTICALS | 7,834 | -1,98 % | BioCryst Pharmaceuticals, Inc.: BioCryst Announces Sale of European ORLADEYO (berotralstat) Business to Neopharmed Gentili for up to $264 Million | -Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future milestones-
-BioCryst plans to use proceeds to... ► Artikel lesen | |
DYNAVAX | 8,482 | +0,24 % | Dynavax Technologies: Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum | Deep Track's Misleading Investor Presentation Demonstrates its Single-Minded Approach to Abandon Long-Term Value Opportunities in Exchange for Short-Term Return
Urges... ► Artikel lesen | |
REDHILL BIOPHARMA | 1,770 | -2,75 % | RedHill Biopharma Ltd. - F-1, Registration statement for certain foreign private issuers |